Becker's Healthcare August 2, 2024
The FDA has approved the gene therapy Tecelra for treatment of synovial sarcoma.
Tecelra, developed by biopharmaceutical company Adaptimmune, is the first gene therapy treatment for adult patients with unresectable or metastatic synovial sarcoma to be approved by the FDA, according to an Aug. 2 news release from the agency.
Synovial sarcoma...